MONOTX
LIVE

Serial Number

88221562

Owner

Mononuclear Therapeutics Limited

Attorney

Susan J. Brushaber

First Use Date

Nov 1, 2019

Filing Date

Dec 7, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MONOTX Trademark

Serial Number: 88221562 • Registration: 6137042

MONOTX is a trademark filed by Mononuclear Therapeutics Limited on December 7, 2018. The trademark is classified under Class 39 (Transportation & Storage), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Mononuclear Therapeutics Limited (3 trademarks)

Unit 323, Bldg 16W, HK Science Park
Shatin NT , HK

Entity Type: 16

Trademark Details

Filing Date

December 7, 2018

Registration Date

August 25, 2020

First Use Anywhere

November 1, 2019

First Use in Commerce

November 1, 2019

Published for Opposition

October 15, 2019

Goods & Services

Storage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use

Collection and testing of cord blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body

Research and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of monuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 25, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 22, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 22, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 23, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 22, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 30, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 30, 2020 AITU
USE AMENDMENT FILED
Jun 10, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 10, 2020 EISU
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2020 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 10, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2019 PUBO
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2019 REAP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2019 NONP
ASSIGNED TO LIE
Sep 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 8, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 13, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 13, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 13, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2018 NWOS
NEW APPLICATION ENTERED
Dec 11, 2018 NWAP